A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis

Figure 6

An application of the m5CPS in the nomogram. (a) The nomogram based on the GAP and m5CPS, the red dots in the nomogram represent the clinical features of patient GSM1820740. (b) Calibration curves assess the accuracy of the nomogram in predicting the survival probabilities of IPF individuals. (c) Decision curve analysis (DCA) demonstrates the positive net benefits of the nomogram for IPF patients.

(a)

(b)

(c)